Cinemo Partners With NIO to Bring Home-Entertainment-Grade Experience to Its Premium Electric Vehicles
Cinemo, a global leader in high-performance and automotive-grade multimedia playback, streaming, media management, connectivity, and cloud middleware, has partnered with NIO – a leader in the premium smart electric vehicle market – to deliver a home-entertainment-like in-car experience to NIO users in Europe.
With the introduction of the ET7, EL7, ET5, ET5 Touring, EL6 and EL8 models in Europe, NIO is raising the bar for premium in-car entertainment. Powered by Cinemo’s CARS Online Video, journeys are turned into a memorable, shared digital media experience for family and friends.
NIO users can now enjoy their favorite movies and TV series together, from the comfort of their electric vehicle. This experience can be accessed effortlessly from the vehicle’s center display. Through NIO’s SOTA (software-over-the-air) and FOTA (firmware-over-the-air) updates, new features, integrations and functionality are automatically added to its premium entertainment unit.
The Cinemo CARS™ product portfolio, selected by NIO to deliver its exceptional entertainment experiences, is designed for easy integration and quick time to market. Built to enrich the Android Automotive Operating System, Cinemo CARS™ features complete and customizable applications, making it the ideal media solution to complement and enhance Android’s offering with different scenarios, such as multi-screen, premium video-on-demand and immersive audio, delivering a world of entertainment for all passengers. To ensure safety while driving, Cinemo CARS™ products support Android Car User Experience Restrictions.
“We’re delighted to be partnering with Cinemo to provide our users with best-in-class video-on-demand experiences,” says Benjamin Steinmetz, Product Experience Director at NIO. “The support from the Cinemo team has been instrumental in achieving our vision to take NIO’s digital multimedia experience to the next level. Using Cinemo’s suite of advanced multimedia solutions ensures we can always provide our users with the latest in-vehicle digital media experiences.”
Elif Ede, VP Strategy at Cinemo adds: “We are passionate to deliver groundbreaking innovations to create future-ready infotainment solutions that not only deliver a premium experience today, but which are also primed for the next wave of in-vehicle innovation. We are excited to bring home-entertainment-like experiences to NIO users.”
About NIO Inc.:
NIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users.
NIO designs, develops, jointly manufactures, and sells premium smart electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS.
NIO’s product portfolio consists of the ES8, a six-seater smart electric flagship SUV, the ES7 (or the EL7), a mid-large five-seater smart electric SUV, the ES6 (or the EL6), a five-seater all-round smart electric SUV, the EC7, a five-seater smart electric flagship coupe SUV, the EC6, a five-seater smart electric coupe SUV, the ET7, a smart electric flagship sedan, the ET5, a mid-size smart electric sedan, the ET5T, a smart electric tourer, and its smart electric executive flagship, the ET9.
About Cinemo:
Cinemo is a global provider of highly innovative infotainment products that make every screen an opportunity. Its range of award-winning, fully integrated, low-footprint digital media offerings combine high performance with high quality and are truly system agnostic.
Whether embedded, as mobile apps or through the cloud, Cinemo supports all digital media scenarios for any industry and any device. Its product portfolio is designed and built to deliver excellence, accelerate time to market, and lower TCO for its clients while creating digital media experiences that matter.
Founded in 2008, and with a strong history of industry firsts, Cinemo is the partner of choice for more than 40 market-leading OEMs and over 20 tier-1s. The company works with the top high-tech and consumer electronic companies as well as global music and video content providers. Cinemo’s global team of 300+ innovative thinkers from 40 nationalities continuously delivers groundbreaking innovation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240621955542/en/
Contacts
Press:
NIO | Julia Valenzuela-Bock, Senior PR Manager Europe (Julia.bock@nio.io)
Cinemo | Martina Oerther, Marketing Director (moerther@cinemo.com)
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zambon Announces Publication of Phase 3 PROMIS I and II Study Results in The Lancet Respiratory Medicine Showing Efficacy Results of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis Colonized with P. aeruginosa13.9.2024 11:00:00 CEST | Press release
Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives, today announced the online publication of its Phase 3 PROMIS-I and PROMIS-II studies in The Lancet Respiratory Medicinejournal. The PROMIS studies assessed the efficacy and safety of inhaled colistimethate sodium administered via the I-neb® Adaptive Aerosol Delivery System (“CMS I-neb”) as a treatment to reduce the frequency of pulmonary exacerbations in patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) chronically colonized with P. aeruginosa over 12 months, compared to placebo. “The publication of these pivotal data in The Lancet Respiratory Medicine represents an important milestone in our commitment to developing innovative therapies for patients with severe respiratory diseases,” said Paola Castellani, Chief Medical Officer and R&D Head at Zambon. “For patients with NCFB, a condition with no approved treatment options, the results
Intelsat Signs Hybrid Media Deal Distributing Hearst Networks EMEA Content13.9.2024 09:00:00 CEST | Press release
Intelsat, operator of one of the world’s largest integrated satellite and terrestrial networks, successfully launched a hybrid television content distribution service to deliver Hearst Networks EMEA (formerly known as A+E Networks EMEA) channels to hundreds of points across Europe thanks to its seamless satellite-terrestrial connection. “Growing global media customers like Hearst Networks EMEA want to work with a single operator that can provide seamless connections from satellite to ground-based Internet Protocol distribution networks,” said Rhys Morgan, regional vice president, EMEA, Media and Networks. “Intelsat has visibility across the full distribution network, even when it spans multiple technologies and can enable customers to reach more end users.” In order to reach a wide group of viewers, content providers typically use multiple distribution mediums such as direct-to-home (DTH), cable and IPTV. Hearst Networks EMEA needed to maximize the reach of its flagship channels, The H
NATO Support and Procurement Agency Contracts SES’s O3b mPOWER for Secure Communications Services13.9.2024 08:30:00 CEST | Press release
The NATO Support and Procurement Agency (NSPA) has awarded SES a contract to deliver secure high-performance low-latency satellite services via its medium earth orbit (MEO) constellation, enabling global missions for NATO member government organisations, agencies and military. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910404747/en/ NATO Support and Procurement Agency Contracts SES’s O3b mPOWER for Secure Communications Services (Photo: Business Wire) The MEO Global Services (MGS) award represents a three-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at USD 200M, with two one-year options. This is the first award under the Global Commercially Contracted Satellite Communications Support Partnership (GCC SATCOM SP) established by the U.S. and Luxembourg under the auspices of NSPA in 2022, opening a new era of space cooperation within NATO. The MGS will be available to all NATO countries, including
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types13.9.2024 08:00:00 CEST | Press release
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data from several studies utilizing Guardant technology to advance precision oncology at the European Society for Medical Oncology Congress (ESMO) in Barcelona, Spain, Sept. 13-17, 2024. Data on the Guardant Reveal™ minimal residual disease test in locally advanced rectal cancer patients enrolled in the NO-CUT trial will be presented in a proffered paper session during Presidential Symposium III. Other presentations will include findings from studies evaluating Guardant360® for therapy selection in advanced breast cancer and other solid tumors, and the Guardant Infinity™ platform for response monitoring in advanced non-small cell lung cancer (NSCLC). “Our latest data featured at ESMO further highlight the value of Guardant’s technology in precision oncology and the critical role liquid biopsy can play in informing therapy selection and treatm
SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.13.9.2024 08:00:00 CEST | Press release
SamanTree Medical, a leader in innovative surgical imaging solutions, today announced that it has received FDA 510(k) clearance of its Histolog® Scanner for imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture. This groundbreaking Swiss made device is designed to provide real-time, highresolution imaging of fresh tissue surfaces, offering surgeons and pathologists this information for excised tissue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240912995435/en/ The Histolog Scanner in use for rapid visualization of fresh tissue microstructures. (Photo: SamanTree Medical) The Histolog® Scanner enables real-time, ultra-fast confocal microscopy, allowing for the immediate imaging of resected tissues. This advancement aims to enable physicians to improve their efficiency. “We are thrilled to introduce the Histolog® Scanner t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom